# Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose

> **NCT02212548** · NA · COMPLETED · sponsor: **Royal North Shore Hospital** · enrollment: 30 (actual)

## Conditions studied

- Cancer of the Prostate

## Interventions

- **DEVICE:** PEG Hydrogel (SpaceOAR)

## Key facts

- **NCT ID:** NCT02212548
- **Lead sponsor:** Royal North Shore Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-12
- **Final completion:** 2016-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02212548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02212548, "Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02212548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*